Breaking down walls in prostate cancer with the MURAL collection of patient-derived xenografts
A bank of 59 well-characterised prostate cancer patient-derived xenografts was established, including 17 classed as research-ready covering the disease-spectrum which, plus associated resources (organoids, serum, DNA/RNA profiles, tissue), are available for collaborative projects. This eagerly-antic...
Enregistré dans:
Auteur principal: | Charlotte L. Bevan |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/feb3485b07fb4d0dbd2023b9e45716e3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology
par: Gail P. Risbridger, et autres
Publié: (2021) -
Patient-derived xenografts and organoids model therapy response in prostate cancer
par: Sofia Karkampouna, et autres
Publié: (2021) -
Breaking Down the LMS Walls
par: Michael Hotrum
Publié: (2005) -
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
par: Massimo Moro, et autres
Publié: (2017) -
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
par: Miguel Martin, et autres
Publié: (2021)